Valuation : Anpario plc

Market Cap 108M 146M 126M 119M 202M 13.81B 204M 1.41B 546M 7.06B 549M 537M 23.19B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 93.68M 127M 109M 103M 175M 11.95B 176M 1.22B 472M 6.11B 475M 465M 20.07B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.68x
Free-Float
71.2%
Yield 2026 *
2.49%
Yield 2027 * 2.57%
1 week+2.88%
Current month-0.19%
1 month+0.94%
3 months-3.25%
Current year+12.63%
1 week 519.81
Extreme 519.8125
540
1 month 500
Extreme 500
540
Current year 391.11
Extreme 391.11
580
1 year 391.11
Extreme 391.11
580
3 years 200
Extreme 200
580
5 years 177
Extreme 177
710
10 years 177
Extreme 177
729.6
Manager TitleAgeSince
Chief Executive Officer 61 12/01/2016
Director of Finance/CFO - 30/06/2021
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/11/2006
Director/Board Member 66 30/09/2009
Chairman 67 28/06/2023
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/25 Buy

Chief Financial Officer

3,778 0.0185%
02/04/25 Buy

Chief Financial Officer

5,010 0.0245%
02/04/25 Sell

Chief Financial Officer

7,621 0.0373%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.88%+30.49%+151.76% 146M
-0.67%+3.65%-24.43%-2.98% 11.31B
-2.08%+0.71%-27.66%-39.66% 4.7B
-0.98%+2.02%-30.02%-40.88% 2.81B
+0.38%+2.77%+33.33%+53.85% 2.73B
-5.67%+1.83%-21.65%-49.00% 2.12B
+2.29%+7.93%-34.11%-64.15% 1.27B
-0.98%-5.91%+18.37%+82.42% 1.16B
-2.42%+3.46%+5.63%-6.60% 837M
-0.92%+0.31%-24.71%-26.58% 832M
Average -1.09%+0.97%-7.48%+5.82% 2.79B
Weighted average by Cap. -1.14%+1.18%-17.16%-10.14%

Financials

2026 *2027 *
Net sales 50.35M 67.99M 58.66M 55.26M 94.1M 6.42B 94.81M 654M 254M 3.28B 255M 250M 10.79B 52.52M 70.92M 61.19M 57.64M 98.16M 6.7B 98.9M 682M 265M 3.43B 266M 261M 11.25B
Net income - -
Net Debt -14.55M -19.65M -16.95M -15.97M -27.19M -1.86B -27.4M -189M -73.36M -949M -73.78M -72.16M -3.12B -20.04M -27.06M -23.35M -21.99M -37.46M -2.56B -37.74M -260M -101M -1.31B -102M -99.4M -4.29B
Logo Anpario plc
Anpario plc is a United Kingdom-based independent manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity. The Company’s addictive solutions include poultry, ruminant, swine, aqua and feed mill. Its product categories include health & performance, toxin management, feed quality, and hygiene & insect control. Its health & performance products include Orego-Stim Range, Orego-Stim Range (Aqua), pHorce Range, Salkil Range, Optomega Range and Genex Range. Its toxin management products include Anpro Range and Anpro Advance. Its feed quality products include pHorce Range, Salgard Range, Mastercube Range, Moldgard, Oxigard Range and Feedzyme Range. Its technologies are sold in over 80 countries through established sales and distribution networks, which include a number of wholly owned subsidiaries.
Employees
162
Date Price Change Volume
02/09/26 GBX 535.00 0.00% 3,718
01/09/26 GBX 535.00 -0.19% 38,571
28/08/26 GBX 536.00 +2.10% 72,501
27/08/26 GBX 525.00 +0.96% 3,966
26/08/26 GBX 520.00 0.00% 92,453
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.350GBP
Average target price
5.980GBP
Spread / Average Target
+11.78%

Net sales - Rate of surprise